149 related articles for article (PubMed ID: 35462440)
1. Diet quality is associated with primary melanoma thickness.
Hughes MCB; Malt M; Khosrotehrani K; Smithers BM; Green AC
J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):1745-1750. PubMed ID: 35462440
[TBL] [Abstract][Full Text] [Related]
2. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98.
Schmid-Wendtner MH; Baumert J; Eberle J; Plewig G; Volkenandt M; Sander CA
Br J Dermatol; 2003 Oct; 149(4):788-93. PubMed ID: 14616371
[TBL] [Abstract][Full Text] [Related]
3. Factors related to the presentation of patients with thick primary melanomas.
Hersey P; Sillar RW; Howe CG; Burton RC; Darbar SV; Foster HM; Collins SM; Bradley DE; Owens D
Med J Aust; 1991 May; 154(9):583-7. PubMed ID: 2056943
[TBL] [Abstract][Full Text] [Related]
4. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness.
Crocetti E; Carli P
Eur J Dermatol; 2003; 13(1):72-5. PubMed ID: 12609787
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Omega-3 and Omega-6 Fatty Acid Dietary Intake and Melanoma Thickness at Diagnosis.
Mahamat-Saleh Y; Hughes MCB; Miura K; Malt MK; von Schuckmann L; Khosrotehrani K; Smithers BM; Green AC
Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1647-1653. PubMed ID: 32430338
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.
Dodds TJ; Lo S; Jackett L; Nieweg O; Thompson JF; Scolyer RA
Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with a high tumour thickness in patients with melanoma.
Baumert J; Plewig G; Volkenandt M; Schmid-Wendtner MH
Br J Dermatol; 2007 May; 156(5):938-44. PubMed ID: 17381454
[TBL] [Abstract][Full Text] [Related]
8. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
[TBL] [Abstract][Full Text] [Related]
9. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report.
Esmaeli B; Youssef A; Naderi A; Ahmadi MA; Meyer DR; McNab A;
Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):96-101. PubMed ID: 12644753
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of ulceration of cutaneous melanoma.
Balch CM; Wilkerson JA; Murad TM; Soong SJ; Ingalls AL; Maddox WA
Cancer; 1980 Jun; 45(12):3012-7. PubMed ID: 7388745
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1997 Jan; 79(2):275-83. PubMed ID: 9010101
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D deficiency at melanoma diagnosis is associated with higher Breslow thickness.
Wyatt C; Lucas RM; Hurst C; Kimlin MG
PLoS One; 2015; 10(5):e0126394. PubMed ID: 25970336
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.
Wei X; Wu D; Chen Y; Li H; Zhang R; Yao H; Chi Z; Cui C; Bai X; Mao L; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Lian B; Kong Y; Dai J; Tang B; Wang X; Guo J; Si L
Br J Dermatol; 2022 Jun; 186(6):977-987. PubMed ID: 35042273
[TBL] [Abstract][Full Text] [Related]
14. Anthropometric factors and Breslow thickness: prospective data on 2570 cases of cutaneous melanoma in the population-based Janus Cohort.
Stenehjem JS; Veierød MB; Nilsen LT; Ghiasvand R; Johnsen B; Grimsrud TK; Babigumira R; Støer NC; Rees JR; Robsahm TE
Br J Dermatol; 2018 Sep; 179(3):632-641. PubMed ID: 29858512
[TBL] [Abstract][Full Text] [Related]
15. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past.
Crocetti E; Caldarella A; Chiarugi A; Nardini P; Zappa M
Melanoma Res; 2010 Oct; 20(5):422-6. PubMed ID: 20679908
[TBL] [Abstract][Full Text] [Related]
16. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
[TBL] [Abstract][Full Text] [Related]
17. Clinical correlates of Breslow thickness of malignant melanoma.
Osborne JE; Hutchinson PE
Br J Dermatol; 2001 Mar; 144(3):476-83. PubMed ID: 11260002
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors.
Lo SN; Scolyer RA; Thompson JF
Ann Surg Oncol; 2018 Apr; 25(4):894-902. PubMed ID: 29330716
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institution.
Hinz T; Ahmadzadehfar H; Wierzbicki A; Hoeller T; Wenzel J; Biersack HJ; Bieber T; Schmid-Wendtner MH
Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1316-25. PubMed ID: 22618833
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]